Form 8-K - Current report:
SEC Accession No. 0001213900-25-059702
Filing Date
2025-06-30
Accepted
2025-06-30 16:44:29
Documents
19
Period of Report
2025-06-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0247458-8k_cormedix.htm   iXBRL 8-K 29956
2 UNDERWRITING AGREEMENT DATED JUNE 26, 2025 ea024745801ex1-1_cormedix.htm EX-1.1 219744
3 OPINION OF WILLKIE FARR & GALLAGHER LLP ea024745801ex5-1_cormedix.htm EX-5.1 11238
4 PRESS RELEASE DATED JUNE 26, 2025 ANNOUNCING THE COMMENCEMENT OF THE OFFERING ea024745801ex99-1_cormedix.htm EX-99.1 12997
5 PRESS RELEASE DATED JUNE 27, 2025 ANNOUNCING THE PRICING OF THE OFFERING ea024745801ex99-2_cormedix.htm EX-99.2 10648
6 GRAPHIC ex5-1_001.jpg GRAPHIC 10259
7 GRAPHIC ex99-1_001.jpg GRAPHIC 15569
8 GRAPHIC ex99-2_001.jpg GRAPHIC 14436
  Complete submission text file 0001213900-25-059702.txt   573329

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE crmd-20250626.xsd EX-101.SCH 3014
10 XBRL LABEL FILE crmd-20250626_lab.xml EX-101.LAB 34239
11 XBRL PRESENTATION FILE crmd-20250626_pre.xml EX-101.PRE 22358
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0247458-8k_cormedix_htm.xml XML 3671
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 251092735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)